Stephan Kemp
Overview
Explore the profile of Stephan Kemp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
3375
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Ferrer R, Jaspers Y, Dijkstra I, Breeuwsma N, van Klinken J, Romero C, et al.
J Inherit Metab Dis
. 2024 Dec;
48(1):e12832.
PMID: 39704488
X-linked adrenoleukodystrophy (ALD) is a peroxisomal disorder resulting from pathogenic variants in the ABCD1 gene that primarily affects the nervous system and is characterized by progressive axonal degeneration in the...
3.
Loix M, Vanherle S, Turri M, Kemp S, Fernandes K, Hendriks J, et al.
Mol Neurodegener
. 2024 Nov;
19(1):85.
PMID: 39563397
Disturbances in the fatty acid lipidome are increasingly recognized as key drivers in the progression of various brain disorders. In this review article, we delve into the impact of Δ9...
4.
Vasireddy V, Maguire C, Anderson D, Ng C, Gong Y, Eichler F, et al.
Mol Ther Methods Clin Dev
. 2024 Nov;
32(4):101354.
PMID: 39524975
Adrenomyeloneuropathy is a progressive neurodegenerative disease caused by pathogenic variants in the gene, resulting in very-long-chain fatty acid (VLCFA) accumulation that leads to dying-back axonopathy. Our candidate gene therapy, SBT101...
5.
Engelen M, Kemp S, Eichler F
Handb Clin Neurol
. 2024 Sep;
204:133-138.
PMID: 39322375
X-linked adrenoleukodystrophy (ALD) is a peroxisomal disorder caused by mutations in the ABCD1 gene and characterized by impaired very long-chain fatty acid beta-oxidation. Clinically, male patients develop adrenal failure and...
6.
Jaspers Y, Yska H, Bergner C, Dijkstra I, Huffnagel I, Voermans M, et al.
Commun Med (Lond)
. 2024 Sep;
4(1):175.
PMID: 39256476
Background: X-linked adrenoleukodystrophy (ALD) is a neurometabolic disorder caused by pathogenic variants in ABCD1 resulting very long-chain fatty acids (VLCFA) accumulation in plasma and tissues. Males can present with various...
7.
Gupta A, Furcich J, Nascene D, Kemp S, King C, Nolan E, et al.
J Neuroimmunol
. 2024 Jun;
393:578395.
PMID: 38897089
The earliest clinical manifestation of cerebral adrenoleukodystrophy (CALD) is adrenal insufficiency (AI) characterized by elevations in ACTH and loss of cortisol. We showed high (though physiologically achievable) levels of ACTH...
8.
Jaspers Y, Meyer S, Pras-Raves M, Dijkstra I, Wever E, Dane A, et al.
J Lipid Res
. 2024 May;
65(6):100567.
PMID: 38795862
Lipids play pivotal roles in an extensive range of metabolic and physiological processes. In recent years, the convergence of trapped ion mobility spectrometry and MS has enabled 4D-lipidomics, a highly...
9.
Kanefsky J, Basse M, Sokei J, Di Martino O, Valin L, Jaspers Y, et al.
J Biol Chem
. 2024 Mar;
300(5):107214.
PMID: 38522521
The role of polyunsaturated fatty acid (PUFA) biosynthesis in acute myeloid leukemia (AML) remains largely undefined. A comparative expression analysis of 35 genes encoding fatty acid biosynthesis enzymes showed that...
10.
Eggelbusch M, Charlton B, Bosutti A, Ganse B, Giakoumaki I, Grootemaat A, et al.
Cell Rep Med
. 2024 Jan;
5(1):101372.
PMID: 38232697
Insulin sensitivity and metabolic flexibility decrease in response to bed rest, but the temporal and causal adaptations in human skeletal muscle metabolism are not fully defined. Here, we use an...